Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population
Giacomo Boffa, Nicolò Bruschi, Maria Cellerino, Caterina Lapucci, Giovanni Novi, Elvira Sbragia, Elisabetta Capello, Antonio Uccelli, Matilde Inglese
Topics & Concepts
FingolimodDimethyl fumarateMedicineMultiple sclerosisExpanded Disability Status ScaleInternal medicinePopulationNatalizumabAdverse effectCohortImmunologyEnvironmental healthMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersSphingolipid Metabolism and Signaling